Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 3
Study Completion Date
January 2015
NCT00070564Uploaded 08-12-2017
Access via NCI by Request
PDS UID: nci-data-348
Phase III Trial of Continuous Schedule AC + G vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node-Negative Breast Cancer
Files: NCT00070564-D2
Data DictionaryNCT00070564-D2-Data-Dictionary.pdf
DATANCT00070564-D2-Dataset.txt
OTHERREADME.pdf
Files: NCT00070564-D1
Data DictionaryNCT00070564-D1-Data-Dictionary.pdf
DATANCT00070564-D1-Dataset.txt
OTHERREADME.pdf